Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

68
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
68
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

80
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
80
Veins of Lower Limbs01:15

Veins of Lower Limbs

1.6K
The human body consists of an intricate network of veins responsible for the crucial task of blood drainage from the lower limbs. These veins can be categorized into two main types: deep veins and superficial veins.
Formed by the union of the medial and lateral plantar veins, the posterior tibial vein, rising through the calf muscle, assimilates the fibular vein. The anterior tibial vein, a superior extension of the foot's dorsalis pedis vein, merges with the posterior tibial vein at the...
1.6K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

60
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
60
Varicose Veins I: Introduction01:26

Varicose Veins I: Introduction

44
Varicose veins, or varicosities, are abnormally dilated and twisted superficial veins caused by venous valve incompetence. This condition commonly affects the lower extremities, especially the saphenous veins, due to the higher pressure from prolonged standing and walking. However, varicosities can also occur in other areas, such as the esophagus, vulva, spermatic cords, and anorectal region.Etiology and typesPrimary varicose veins, often idiopathic, are more common in women due to inherent...
44
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

50
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
50

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD.

Journal of the American Heart Association·2025
Same author

Early Risk of Major Adverse Limb Events Following Lower Extremity Revascularization in the VOYAGER-PAD Trial.

JACC. Cardiovascular interventions·2025
Same author

Dual pathway inhibition in patients with coronary artery disease (CAD) in clinical practice in Germany: results from the German CAD subgroup of the XATOA Registry.

Clinical research in cardiology : official journal of the German Cardiac Society·2025
Same author

Dual pathway inhibition in patients with peripheral artery disease in Germany.

VASA. Zeitschrift fur Gefasskrankheiten·2025
Same author

Danaparoid-Consensus Recommendations on Its Clinical Use.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD.

Circulation·2024
Same journal

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

["Not everything that looks like a tumor..." - Pulmonary tularemia with hilar lymphadenopathy].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Emergency management of sickle cell disease].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Hereditary dehydrated stomatocytosis (= hereditary xerocytosis) - Interesting hummingbird or clinically relevant diagnosis?]

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Diagnosis of Congenital Hemolytic Anemias in Adults].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[46-year-old female patient with right upper abdominal pain].

Deutsche medizinische Wochenschrift (1946)·2026
See all related articles

Related Experiment Video

Updated: Oct 19, 2025

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

14.6K

[Superficial Vein Thrombosis].

Rupert M Bauersachs1

  • 1Klinik für Gefäßmedizin - Angiologie, Klinikum Darmstadt GmbH.

Deutsche Medizinische Wochenschrift (1946)
|September 23, 2021
PubMed
Summary
This summary is machine-generated.

Superficial vein thrombosis (SVT) management varies significantly, with a substantial risk of venous thromboembolism (VTE) despite initial anticoagulation. Current guidelines are not consistently followed, necessitating further research into optimal treatment durations.

More Related Videos

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography
06:44

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography

Published on: April 13, 2018

10.2K
Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis
05:37

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis

Published on: December 22, 2017

25.0K

Related Experiment Videos

Last Updated: Oct 19, 2025

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

14.6K
Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography
06:44

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography

Published on: April 13, 2018

10.2K
Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis
05:37

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis

Published on: December 22, 2017

25.0K

Area of Science:

  • Vascular Medicine
  • Thrombosis Research
  • Clinical Epidemiology

Background:

  • Superficial vein thrombosis (SVT) patient profiles, clinical presentation, and treatment are highly variable.
  • A significant risk of subsequent venous thromboembolism (VTE), recurrence, or extension exists within three months post-SVT.
  • Current guidelines are inconsistently applied, with one-third of patients receiving inappropriate anticoagulation or none.

Purpose of the Study:

  • To analyze risk profiles, clinical presentation, and treatment patterns in a large cohort of superficial vein thrombosis (SVT) patients.
  • To identify risk factors associated with concomitant VTE at presentation and thromboembolic complications during follow-up.
  • To evaluate the effectiveness and adherence to current treatment guidelines for SVT.

Main Methods:

  • Analysis of a large German registry documenting superficial vein thrombosis (SVT) cases.
  • Identification of risk factors for concomitant VTE and follow-up thromboembolic events.
  • Review of treatment patterns, including anticoagulation modalities, intensities, and durations, compared against guideline recommendations.

Main Results:

  • High variability observed in SVT patient risk profiles, presentation, and treatment, including anticoagulation.
  • Approximately 25% of SVT patients present with concomitant VTE, often asymptomatic.
  • Identified risk factors for VTE include prior hospitalization, immobilization, prior VTE, autoimmune disorders, older age, and cancer.

Conclusions:

  • Superficial vein thrombosis (SVT) management requires personalized risk assessment due to variable patient factors and treatment responses.
  • Concomitant VTE is common in SVT patients, highlighting the need for thorough initial evaluation.
  • Further research is needed to optimize anticoagulation duration and strategies, particularly for high-risk SVT patients, to prevent VTE recurrence.